Artherosclerosis
Weight gain during intensive therapy put diabetics at risk for atherosclerosis
Published in Obesity and Diabetes Week, July 4th, 2005
"Type 1 diabetes mellitus is associated with an increased risk of cardiovascular disease (CVD) that is not fully explained by conventional risk factors. The Diabetes Control and Complications Trial (DCCT) showed that intensive diabetes therapy reduced levels of LDL cholesterol and triglycerides but increased the risk of major weight gain, which might adversely affect CVD risk," researchers in the United States reported in a recent issue of Circulation.
D.A. Schaumberg and colleagues, Brigham and Womens Hospital, Boston explained, "The present study examined the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
A higher low-fat dairy intake decreases men's risk of type 2 diabetes - Diabetes Pathogenesis
Glucagon-like peptide-1 linked to metabolic abnormalities - Metabolic Syndrome
Strategies against metabolic syndrome should include a look at adiponectin - Obesity Pathogenesis
Mother's body mass index associated with son's waist circumference - Obesity and Diabetes
Nutrition, BMI, and glycemic control assessed in diabetic patients - Adipose Tissue
Altered adipokine levels linked with inflammatory conditions - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
